Food and Nutrition Grants

The main objective of this NOFO is to foster development and testing of technologies adaptable to aging-related changes in older adults (aged 65 years or older) with T1D to improve diabetes management and quality of life. Older adults may have increased vulnerability to hypoglycemia, cognitive impairment and/or multiple co-morbidities which may affect the risks and benefits of these technologies in this population. Projects will be funded to a) develop and test new technologies and b) to adapt and test existing technologies. It is expected that aging-adaptive diabetes technologies that address barriers for use among older adults with T1D will improve usability, adoption and adherence decreasing the risk of hypoglycemia (and hypoglycemia unawareness) while enhancing glycemic control, facilitating better diabetes management, and improving quality of life for these individuals and their caregivers.

The Northeast Dairy Business Innovation Center (NE-DBIC) has launched the Goat and Sheep Dairy Development Grant program to bolster the Northeast goat and sheep dairy sector. This initiative aligns with the NE-DBIC's broader mission to strengthen regional dairy industries by addressing critical areas such as business viability, market development, and innovative production methods. The program aims to enhance the growth and long-term viability of individual small ruminant businesses, while also tackling gaps in technical assistance, improving supply chain partnerships, and expanding market access. The program targets several beneficiaries, including dairy farmers (producers) currently or transitioning to producing goat or sheep milk, dairy processors transforming raw goat/sheep milk into edible products, dairy producer associations representing and promoting goat/sheep dairy products, and technical assistance providers working with these groups. The impact goals are to foster growth, increase profitability, improve herd/flock health and milk quality, reduce barriers to new markets, and expand distribution opportunities for goat/sheep dairy products within the Northeast region. The grant program focuses on two main project types: Individual Business Projects and Sector Enhancement Projects. Individual Business Projects support farmers and processors in making improvements to increase business viability, market development, or production innovations. Examples include engaging with technical assistance providers for business improvements, diversification and marketing efforts, research and development of innovative solutions, and purchasing specialized dairy equipment. Sector Enhancement Projects are designed to engage multiple dairy businesses in activities that improve or expand small ruminant production practices or dairy markets, strengthening relationships across the goat/sheep dairy supply chain. Examples include developing tools and resources, improving farmer access to resources, and initial investments to strengthen supply chain relationships. Funding priorities emphasize projects that address at least two of the following: developing resources to fill unmet technical assistance needs, increasing pay price for goat/sheep dairy farmers, producing deliverables for new or transitioning dairy farmers, including educational/information sharing components, fostering collaborative efforts, increasing profits for dairy businesses, improving herd/flock health/nutrition/milk quality, reducing barriers to new markets, developing market channels, and implementing innovative strategies to increase awareness and consumption of goat/sheep dairy products. The program's theory of change appears to be that by investing in these specific areas, both individual businesses and the sector as a whole will experience sustainable growth and increased competitiveness. Individual business grants range from $15,000 to $50,000, requiring a 25% cash and/or in-kind match commitment. Supply chain projects are eligible for grants between $25,000 and $75,000, also with a 25% match commitment. A total of $760,000 is available for this program. The expected outcomes include a more robust and resilient goat and sheep dairy sector in the Northeast, with enhanced business viability for producers and processors, expanded market reach for their products, and a stronger, more collaborative supply chain. The grant period for projects is between 8 and 12 months.

This Notice of Funding Opportunity (NOFO) requests applications to explore human pancreatic tissues and the immune compartment for the discovery of specific signaling or processing pathways that may contribute to the asymptomatic phase of T1D, the discovery of early biomarkers of T1D pathogenesis, the development of diagnostic tools for the detection and staging of early T1D in at-risk or recently-diagnosed individuals, and/or the identification and biological validation of therapeutic targets for the development of preventative or early treatment strategies. Successful applicants will join the Consortium on Beta Cell Death and Survival (CBDS), whose mission is to better define and detect the mechanisms of beta cell stress and destruction central to the development of T1D in humans, with the long-term goal of protecting the residual beta cell mass in T1D patients as early as possible in the disease process, and of preventing the progression to autoimmunity. The CBDS is part of a collaborative research framework, the Human Islet Research Network (HIRN, https://hirnetwork.org/), whose overall mission is to support innovative and collaborative translational research to understand how human beta cells are lost in T1D, and to find innovative strategies to protect and replace functional beta cell mass in humans. This NOFO will only support studies with a primary focus on increasing our understanding of human disease biology (as opposed to rodent or other animal models). This NOFO will not accept applications proposing a clinical trial.

This program provides financial assistance to low-income families to improve their homes' energy efficiency, helping them save on energy costs while ensuring their health and safety.

This Notice of Funding Opportunity (NOFO) invites applications for Diabetes Research Centers (DRCs) that are designed to support and enhance the national research effort in diabetes, its complications, and related endocrine and metabolic diseases. The purpose of this Centers program is to bring together basic and clinical investigators to enhance communication, multidisciplinary collaboration, and effectiveness of ongoing research in Diabetes Research Center topic areas. By providing shared access to specialized technical resources (research cores) and supporting a Pilot and Feasibility Program (P and F), DRCs are intended to create an environment that provides the capability for accomplishments greater than those that would be possible by individual research project grant support alone. New Center programs that bring in diverse perspectives, propose unique scientific themes, or provide innovative resources are encouraged. Emphasis will be placed on Center programs that propose enhanced synergies with other NIDDK-funded programs as well as providing a rich mentoring environment for future diabetes researchers. This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn. Applicants are strongly encouraged to read the NOFO instructions carefully and view the available PEDP guidance material.

The Clean Water Grant Program (CWGP), offered by the County of Cumberland, Pennsylvania, provides financial support for "shovel-ready" initiatives aimed at enhancing local water quality within Cumberland County. While the description doesn't explicitly state a "foundation mission alignment" or "foundation's strategic priorities and theory of change," it can be inferred that the program aligns with broader environmental stewardship and public health goals, likely stemming from the county's responsibility to manage and improve local resources. The program's core objective is to maximize the impact of limited pollution reduction funding by investing in priority water quality projects. The target beneficiaries of the CWGP are diverse, including non-profit 501(c) organizations, municipal governments, educational institutions, and businesses with headquarters in Cumberland County. The impact goals are directly tied to improving local water quality. The program focuses on developing a water quality project backlog to leverage additional funding, pursuing multifaceted pollution reduction strategies with various stakeholders, accelerating progress toward county pollution reduction goals, and institutionalizing an annual project identification process integrated into county CAP development plans. The priorities and focuses of the CWGP revolve around "shovel-ready" projects that deliver tangible water quality improvements. While there is no minimum or maximum grant award, projects with a local match will receive higher priority, indicating a preference for initiatives that demonstrate community investment and shared responsibility. The program anticipates approximately $500,000 will be available for subawards in 2025, with funding decisions at the sole discretion of Cumberland County and contingent upon PADEP approval. Expected outcomes and measurable results include enhanced local water quality, increased leveraging of additional government and nonprofit funding for water quality projects, a more coordinated approach to pollution reduction among various stakeholders, accelerated progress towards county-wide pollution reduction targets, and a sustainable, integrated annual process for identifying and developing water quality initiatives. The grant period for performance is from March 2025 to December 2025, emphasizing a focus on projects that can demonstrate impact within a relatively short timeframe.

This program provides financial assistance to Michigan's food and agriculture businesses to help them meet wastewater regulations and improve their infrastructure.

This funding opportunity provides financial support for researchers developing innovative, non-opioid treatments for various types of pain, with a focus on early-stage studies and collaboration with underrepresented populations.

This funding opportunity provides financial support to nonprofits and public-serving organizations in Chaffee, Custer, Fremont, and Lake Counties, Colorado, to enhance community health, vitality, and various local initiatives.

This program provides essential funding for energy-efficient home improvements to help low-income households in Pennsylvania reduce their energy costs and improve their living conditions.

This funding program provides financial support to local agencies that help low-income individuals and families improve their living conditions and access essential services.

The Ben and Jerry’s Foundation invites applications for its Equity and Justice Grant to support Vermont based, Vermont focused nonprofit organizations addressing racial, economic, social, and environmental disparities and injustice. The foundation seeks innovative programs that pursue fundamental change through a social justice and equity lens. Grants are up to 15,000 dollars, with an average award of about 10,000 dollars. Funding preference is given to efforts such as equity in education and early childcare, access to safe and affordable housing, criminal justice reform, workers’ rights, and equitable access to healthy and affordable food. Eligible applicants are Vermont based 501(c)(3) organizations or projects represented by a 501(c)(3) fiscal agent with total annual operating budgets under 350,000 dollars. The program does not fund requests that solely provide direct services, discretionary or emergency requests, schools, colleges or universities, individuals or scholarships, research or legal expenses, capital or endowment campaigns, government programs, businesses or associations, religious activities, one time events, other foundations or regranting organizations, or work outside Vermont. Applications are due May 1, 2024 through the foundation’s process. Grant duration is not stated. Official information is available from the Ben and Jerry’s Foundation.

This program provides financial support to municipalities for revitalizing underutilized areas, creating jobs, and boosting local economies through the development of designated zones.

The COVID-19 PA Hazard Pay Grant Program was established to help employers provide hazard pay to employees in life-sustaining occupations during the coronavirus (COVID-19) pandemic. Hazard pay is intended to keep front-line employees working in sectors that are vital to every Pennsylvanians’ existence. The program will help employers provide hazard pay for their employees to retain current employees. This reimbursement-based grant is for employers who will be offering hazard pay over the eligible program period. For general questions about the program or specific application questions, visit our Hazard Pay FAQs. Hazard Pay FAQs Financial Info: The COVID-19 PA Hazard Pay Grant Program was established to help employers provide hazard pay to employees in life-sustaining occupations during the coronavirus (COVID-19) pandemic. Hazard pay is intended to keep front-line employees working in sectors that are vital to every Pennsylvanians’ existence. The program will help employers provide hazard pay for their employees to retain current employees. This reimbursement-based grant is for employers who will be offering hazard pay over the eligible program period. For general questions about the program or specific application questions, visit our Hazard Pay FAQs. Hazard Pay FAQs

The COVID-19 Vaccine Outreach Grant Program supports the efforts of local organizations in Pennsylvania conducting grassroots outreach to communities about COVID-19 vaccines. Organizations will work to educate their communities on COVID-19 vaccines to improve usage of the vaccine, and overall, the health and safety of Pennsylvania. This program will engage and provide the necessary funding to community organizations to educate their community regarding COVID-19 vaccination to address hesitancy concerns and barriers. The COVID-19 Vaccine Outreach Grant Program is a federally funded program. Applicants will need a Data Universal Number System (DUNS) number in order to apply for funding and be registered with the System for Award Management (SAM) in order to receive funding under the program. To register for a DUNS number please visit Dun & Bradstreet website. To obtain a SAM number, visit the SAM website. Dun & Bradstreet website SAM website For general questions about the program, reporting, reimbursement, or outreach efforts in Philadelphia, visit the Vaccine Outreach Grant Program Frequently Asked Questions webpage. Vaccine Outreach Grant Program Frequently Asked Questions webpage Financial Info: The COVID-19 Vaccine Outreach Grant Program supports the efforts of local organizations in Pennsylvania conducting grassroots outreach to communities about COVID-19 vaccines. Organizations will work to educate their communities on COVID-19 vaccines to improve usage of the vaccine, and overall, the health and safety of Pennsylvania. This program will engage and provide the necessary funding to community organizations to educate their community regarding COVID-19 vaccination to address hesitancy concerns and barriers. The COVID-19 Vaccine Outreach Grant Program is a federally funded program. Applicants will need a Data Universal Number System (DUNS) number in order to apply for funding and be registered with the System for Award Management (SAM) in order to receive funding under the program. To register for a DUNS number please visit Dun & Bradstreet website. To obtain a SAM number, visit the SAM website. Dun & Bradstreet website SAM website For general questions about the program, reporting, reimbursement, or outreach efforts in Philadelphia, visit the Vaccine Outreach Grant Program Frequently Asked Questions webpage. Vaccine Outreach Grant Program Frequently Asked Questions webpage

This funding opportunity supports innovative pilot research projects that explore the biological, behavioral, and social factors influencing HIV-related health issues, particularly those affecting kidney and digestive diseases.

This funding opportunity provides financial support to early-career faculty at institutions with limited NIH funding to help them establish independent biomedical research programs and enhance student research experiences.

Notice of Funding Opportunity Description The Food and Drug Administration (FDA), Office of Regulatory Affairs (ORA)is announcing the availability of up to $1,125,000 in FY 2024 to be awarded under Limited Competition to State animal food regulatory programs. The intended outcome of this NOFO is to advance efforts for a nationally integrated animal food safety system through the implementation and advancement of the Animal Food Regulatory Program Standards (AFRPS) by State animal food regulatory programs. Applicants must refer to the Eligibility section of this NOFO to determine which funding track they should apply for: AFRPS Development or AFRPS Maintenance. Applicants should take sustainability into account when designing projects proposed under this cooperative agreement to maximize the longevity of resulting outcomes, resources, and program infrastructure beyond the end of the project period. The AFRPS allows for the development of risk-based animal food safety programs by establishing a uniform basis for measuring, evaluating, and improving the performance of State animal food regulatory programs in the Unites States. By achieving and maintaining implementation of these program Standards, Federal and State food regulatory programs can better direct their regulatory activities toward preventing animal food safety hazards, that can cause illness or injury to animals or humans, in facilities that manufacture, process, pack, or hold animal food materials/supplies. Consequently, the safety and security of the United States animal food supply and protection of human public health will improve. The AFRPS are comprised of eleven Standards (See link below in Program Goals Section) which establish foundations for the critical elements that serve as an objective framework to evaluate and improve components of a State animal food program. These elements cover the State animal food program's regulatory foundation, training, inspection program, auditing, animal food-related illness or death and emergency response, enforcement program, outreach activities, planning and resources, laboratory services, sampling program, and assessment and improvement of Standard implementation. Achieving and maintaining implementation of the program Standards will require comprehensive self-assessment on the part of a State program and will encourage continuous improvement and innovation. FDA recognizes that the time required for achieving full implementation of the AFRPS will vary between States. However, all State animal food regulatory programs will be expected to implement improvement plans to ensure continuous improvement and demonstrate that they are moving towards full implementation. State animal food regulatory programs receiving funds under this cooperative agreement will be expected to achieve and maintain full implementation within 5 total year or less of funding under an AFRPS Cooperative Agreement(s). Grantees will achieve and maintain implementation with the AFRPS (most recent published version). For the purpose of this funding opportunity, "full implementation" is defined as the State animal food regulatory program having all elements, systems, and programs, as required in the Program Elements and Documentation sections of the AFRPS; and can demonstrate the use of those elements, systems, or programs. If implementation is not achieved by the end of funding year 5, the State program will provide a detailed improvement plan on how the remaining AFRPS elements and documentation requirements will be fully implemented and demonstrated. The improvement plan will include: A detailed timeline including what needs to be accomplished to implement the element and/or documentation requirement, and when the work will be completed. The outcomes of the work provided under this cooperative agreement are as follows: 1. State animal food regulatory programs will take significant steps to achieve and maintain implementation of the AFRPS, which is recognized as a critical element to creating a national, fully integrated food safety system. 2. State animal food regulatory programs will contribute to the continuous improvement of the AFRPS through attendance at an annual face-to-face meeting, active participation in committees, and other initiatives supporting the AFRPS. 3. Develop strategies for achieving and maintaining implementation of the AFRPS that can be replicated or leveraged across state programs to promote national consistency. 4. Provide a foundation for supporting advisory/regulatory action based upon findings of regulatory activities conducted by State animal food regulatory programs. Only the following State animal food programs will be eligible to apply: State animal food regulatory programs with current FDA animal food safety inspection contracts (providing funding to State animal food regulatory programs) and are also enrolled in the AFRPS, or those that apply for an FDA animal food safety inspection contract and enroll in the AFRPS, are eligible to apply for funding under this cooperative agreement. An animal food safety inspection contract must be executed prior to this cooperative agreement being awarded. A condition of the award will be maintaining a current FDA animal food safety inspection contract in satisfactory condition throughout the cooperative agreement project period. The FDA will provide one year of funding for this project with the hopes of making another NOFO in FY 2025 to help align project objectives, outputs, reporting, terms and conditions, and project periods for all AFRPS project awardees, and to provide continued funding for awardees under this project to achieve the objectives of the project. The anticipated release of another NOFO in FY2025 will also help align project periods for awardees under this NOFO as well as those currently awarded under PAR-20-132 (for which the project period and funding will end on 6/30/2025). For AFRPS, it is anticipated that full implementation of the AFRPS will be achieved within 5 total funding years under an AFRPS Cooperative Agreement(s), based on a verification audit of your program to ensure the elements have been implemented.

Notice of Funding Opportunity Description Background The Food and Drug Administration (FDA) protects the public health by ensuring that medical products intended to be marketed in the United States are safe and effective for their intended use. FDA stakeholders are exploring innovative ways to produce scientific evidence in support of regulatory submissions, including the development of new data sources, study designs, methodologies, and technologies. FDA encourages and facilitates the use of such innovative approaches while ensuring that the scientific evidence supporting marketing approvals meet our high evidentiary standards. The Prescription Drug User Fee Act VII (PDUFA VII) commitment letter represents the product of discussions between the FDA, regulated industry, and public stakeholders, as mandated by Congress. The performance and procedural goals and other commitments specified in the PDUFA VII commitment letter apply to aspects of the human drug review program that are important for facilitating timely access to safe, effective, and innovative new medicines for patients. The commitment letter includes goals relating to the use of digital health technologies (DHTs) to support drug development and review. A DHT is a system that uses computing platforms, connectivity, software, and/or sensors, for health care and related uses. DHTs for remote data acquisition in clinical investigations can include hardware and/or software to perform one or more functions. DHTs may rely on or work with other technologies that support their operation, such as general-purpose computing platforms (e.g., smartphones) and communication networks. Among other activities relating to the use of DHTs, FDA has established a Framework for the Use of DHTs in Drug and Biological Product Development to guide the use of DHT-derived data in regulatory decision-making for drugs (hereinafter Framework ). The Framework highlights FDA’s DHT efforts including workshops and demonstration projects; engagement with stakeholders; establishment of internal processes to support the evaluation of DHTs for use in drug development; promotion of shared learning and consistency regarding DHT-based policy, procedure, and analytic tool development; and publication of guidance documents. In addition, FDA’s webpage DHTs for Drug Development (available at: https://www.fda.gov/science-research/science-and-research-special-topics/digital-health-technologies-dhts-drug-development) provides an overview of the ongoing DHT efforts, including demonstration projects. A variety of project types are welcomed under this NOFO, applicable to drugs and biologics (not devices). FDA is particularly interested in projects that evaluate the use of DHTs in drug development. Project Objectives The overarching goal of this notice of funding opportunity (NOFO) is to explore the role of DHTs (e.g., actigraphy, photography, environmental sensors) in the evaluation of new drugs. These projects may involve engagement with researchers from academia, the biopharmaceutical industry, patient groups, and other stakeholders. The objectives of these projects are to advance DHTs for clinical drug development, expand the ability to capture early manifestations of chronic diseases, determine outcomes in populations with unmet medical needs and enhance convenience for trial participants by allowing for remote data acquisition in clinical investigations. The scope includes, but is not limited to, projects that focus on: Comparing digital measurements to traditional measurements in clinical trials to evaluate drugs Developing and evaluating novel endpoints using DHTs to address unmet needs for drug clinical trials (e.g., use of environmental sensors to capture apnea in pediatric patients) Comparing metrics to evaluate continuous measurements (e.g., maximum activity and stamina) Capturing early manifestations of chronic diseases (e.g., dementia) through the use of DHTs

This funding opportunity provides financial support to institutions with limited NIH funding to enhance their biomedical research capabilities and engage students in scientific inquiry.